Login:
 
Maini A, O’Brien A. Managing cardiovascular risk key in non-alcoholic fatty liver disease. Practitioner July/Aug 2022;266(1860):11-15

Managing cardiovascular risk key in non-alcoholic fatty liver disease

27 Jul 2022Pais-up subscribers

Most people living with non-alcoholic fatty liver disease (NAFLD) are thought to remain undiagnosed and many are asymptomatic. Obesity, hypertension, type 2 diabetes and hyperlipidaemia are risk factors for NAFLD, and NAFLD is considered to be the liver component of metabolic syndrome. Cardiovascular risk should be stratified for all NAFLD patients and any cardiovascular risk factors managed aggressively. Patients should be given lifestyle advice aimed at weight loss and increased physical activity.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.